Zhiqin Instruments Secures Tens of Millions of RMB in Series A Funding to Advance Specialized Mass Spectrometry Commercialization

Recently, Shenzhen CHIN INSTRUMENT Co., Ltd. completed its Series A financing round, raising over tens of millions of yuan. The round was led by Sai Zhi Venture Capital, with participation from Shenzhen High-Tech Investment Group. Existing investors, including Lihe (from the angel round) and Yirui Biology (300942.SZ, from the Angel+ round), made additional investments. Shenzhen High-Tech Investment Group served as the exclusive financial advisor for this financing round.

The funds raised in this round will be primarily used to advance the industrialization of the company’s specialized mass spectrometers; accelerate the research and development of underlying hardware, software, and core components for mass spectrometry; and expand R&D, production, and office facilities, as well as grow the professional team.

Founded in 2018, CHIN INSTRUMENT boasts a founding team from Tsinghua University with over 20 years of experience in mass spectrometry instrument R&D. The company aims to develop cost-effective, domestically produced compact mass spectrometers that match international technical performance and achieve industrialization within ten years, thereby breaking the monopoly held by European, American, and Japanese mass spectrometry companies in the Chinese market.

Dr. Duo Yingxin, General Manager of CHIN INSTRUMENTStatement: Mass spectrometers are the most technology-intensive and capital-intensive high-end analytical instruments. Among numerous analytical testing methods, mass spectrometry is regarded as the gold standard for detection. It has been increasingly widely applied in clinical healthcare, industrial online monitoring, food testing, atmospheric VOC detection, drug testing, and scientific research and education. CHIN INSTRUMENT is firmly committed to the direction of domestic substitution for specialized mass spectrometry, dedicated to delivering Chinese-made compact mass spectrometers to downstream partners and end users, and working together with them to break the monopoly held by international manufacturers.

Dai Changsheng, Partner at Sai Zhi Venture CapitalCurrently, over 95% of the domestic mass spectrometer market share is occupied by manufacturers from developed countries such as those in Europe, the United States, and Japan, with China’s annual imports of mass spectrometers amounting to approximately RMB 10 billion. CHIN INSTRUMENT, leveraging technology transfer from Tsinghua University, holds multiple core patents and has mastered the design of key components. With years of dedicated focus on mass spectrometry R&D, the team is committed to achieving domestic substitution. We are highly optimistic about CHIN INSTRUMENT’s sustained innovation capabilities and firmly believe that the company will break through foreign monopolies and significantly increase the localization rate of components, emerging as a leading enterprise in domestically produced compact specialized mass spectrometers.

Zhao Bin, Deputy General Manager of the Investment Banking Department at Shenzhen High-Tech Investment GroupIt is noted that the core technologies and market for mass spectrometers have long been dominated by foreign manufacturers, representing a typical “chokepoint” sector with an urgent need for “autonomous and controllable” solutions. The core team of CHIN INSTRUMENT hails from Tsinghua University and has cultivated deep expertise in the field of mass spectrometry for many years. The company has mastered the full set of core technologies across the five major modules of mass spectrometers. Currently, it has achieved a breakthrough in miniaturizing mass spectrometers through technological innovations in ion trap technology, while also establishing a presence in the large-scale mass spectrometry segment. The core management team of CHIN INSTRUMENT possesses profound insights into industrial and medical application scenarios, and the commercialization of its related products is progressing smoothly. Therefore, we firmly believe that the company will be the first to break the competitive landscape dominated by foreign brands in the industrial and medical sectors. By continuously launching competitive innovative products grounded in deep scenario understanding and substantial technical accumulation, CHIN INSTRUMENT will become a significant driving force in the domestication of mass spectrometry instruments in China.

Dr. Zhu Hai, Founder of EasyRapid BioIt is indicated that the application of mass spectrometry detection technology in the healthcare and food markets has entered a phase of rapid development, with downstream testing demand gradually driving the domestication of upstream mass spectrometry instruments. National policies encourage breaking import monopolies and achieving the domestic production of high-end scientific instruments. The team at CHIN INSTRUMENT has been deeply engaged in the mass spectrometry industry for many years, mastering core technologies and receiving numerous national, provincial, and municipal awards. The company has initiated preliminary industrialization, with overall costs remaining controllable. In the future, CHIN INSTRUMENT is poised to break import monopolies, accelerate the domestic substitution of differentiated mass spectrometry instruments, and further expand into broader blue-ocean markets.